Alyeska Investment Group’s Precision BioSciences DTIL Stock Holding History

Alyeska Investment Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-138,825	Closed	-$764K	–	700
2026 Q1	$764K	Sell	138,825 -659,175	-83%	-$3.04M	﹤0.01%	581
2025 Q4	$3.32M	Buy	+798,000	New	+$4.53M	0.01%	493
2025 Q1	–	Sell	-100,000	Closed	-$381K	–	545
2024 Q4	$381K	Sell	100,000 -76,382	-43%	-$558K	﹤0.01%	525
2024 Q3	$1.58M	Hold	176,382	–	–	0.01%	435
2024 Q2	$1.72M	Sell	176,382 -73,618	-29%	-$867K	0.01%	424
2024 Q1	$3.39M	Buy	+250,000	New	+$3.06M	0.02%	354
2019 Q3	–	Sell	-3,890	Closed	-$1.55M	–	431
2019 Q2	$1.55M	Sell	3,890 -1,110	-22%	-$447K	0.02%	343
2019 Q1	$2.69M	Buy	+5,000	New	+$2.65M	0.04%	265

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Alyeska Investment Group's DTIL Position: Q2 2026 in Review

Alyeska Investment Group sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 138,825 shares — an estimated $764K sold.

Alyeska Investment Group first reported a position in DTIL in Q1 2019 and held it in 8 quarters. The position peaked at $3.39M in Q1 2024. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Alyeska Investment Group reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
Alyeska Investment Group sold 138,825 Precision BioSciences shares in Q2 2026, an estimated $764K.
Alyeska Investment Group first reported a position in Precision BioSciences in Q1 2019 and held it in 8 quarters.
Alyeska Investment Group's Precision BioSciences position peaked at $3.39M in Q1 2024.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.